Physician profile
David L Seaton
NPI 1487748745
$7,163.31
in general payments reported to CMS, 2019-2025
37 companies · $916 in 2025
The $916 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $845 · 2021: $1,367 · 2022: $1,648 · 2023: $833 · 2024: $1,269 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,018.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,215.73 | 2021-2025 | Ubrelvy, Vraylar |
| Novo Nordisk INC | $875.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $824.48 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $819.54 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $583.96 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.87 | 2021-2025 | Jardiance, Synjardy |
| Astellas Pharma US INC | $255.61 | 2019-2024 | Veozah |
| Pfizer INC. | $254.34 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $216.39 | 2022-2025 | Rexulti |
| Abbott Laboratories | $197.59 | 2022-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $179.95 | 2021-2025 | |
| Amarin Pharma, INC. | $177.83 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $142.15 | 2020-2022 | |
| Almatica Pharma LLC | $135.88 | 2021 | |
| Nestle Healthcare Nutrition INC. | $117.51 | 2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Seaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.